US Patent Issued to NEW FRONTIER LABS on June 17 for "Azelaic acid esters in the treatment of insulin resistance" (Texas Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,735, issued on June 17, was assigned to NEW FRONTIER LABS LLC (San Antonio).

"Azelaic acid esters in the treatment of insulin resistance" was invented by Robert T. Streeper (San Antonio) and Elzbieta Izbicka (San Antonio).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating insulin resistance includes administering to a subject a pharmaceutical composition comprising diethyl azelate. For example, a method of treating insulin resistance includes orally administering to a subject a pharmaceutical composition that includes diethyl azelate at a dosage range from about 0.1 mg/kg/day to about 10 mg/kg/day."

The patent was filed on May 12, 2...